Richard Miller
Chief Executive Officer at CORVUS PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Leiv Lea | M | 70 |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | 22 years |
| Peter Thompson | M | 64 |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | 14 years |
| Michael E. Singer | M | - |
BrainScope Co., Inc.
 BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| Laurie Silver | F | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 15 years |
| Mahendra Shah | M | 79 | 8 years | |
| Laura Berner | F | 49 | 2 years | |
| Kerstin Schultz | F | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 9 years |
| Karen L. Bergman | F | - | - | |
| Ted Wang | M | 57 |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | 4 years |
| Ian Clark | M | 62 | 7 years | |
| Frank Lee | M | 56 | 3 years | |
| Linda Grais | M | 68 | 5 years | |
| William Jones | M | 59 | 5 years | |
| Scott Morrison | M | 66 | 9 years | |
| Brian O'Callaghan | M | 54 | 3 years | |
| Terry Gould | M | 67 | 10 years | |
| Nicole Onetto | M | 71 | 3 years | |
| Grant Yonehiro | M | 60 | 8 years | |
| Miles Gilburne | M | 73 |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 9 years |
| Kathy LaPorte | F | 62 | 4 years | |
| James Healy | M | 59 | 3 years | |
| Sarah Nemec | F | 48 | 4 years | |
| Yu Tai | M | - | - | |
| Wesley Burwell | M | - | 3 years | |
| Peter Dawson Andrews | M | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| Gabriel Luciano | M | - | 6 years | |
| John Tomaro | M | - | 4 years | |
| Priti Hegde | M | 52 | - | |
| Suresh Mahabhashyam | M | - | 5 years | |
| James Rosenbaum | M | - | 2 years | |
| William Quinn | M | 53 | 4 years | |
| Leslie S. Prichep | M | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 34 years |
| Douglas C. Oberly | M | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| Susan Hertzberg | F | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 5 years |
| Jeffrey Arcara | M | - | - | |
| John M. Reher | M | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| James Peake | M | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| Jean N. Case | F | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| Ronald Alan Klain | M | 62 |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 6 years |
| Michael Epstein | M | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 1 years |
| Cynthia Ringo | F | - |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| Ralph Terkowitz | M | 73 |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | 1 years |
| Gail Wilensky | M | 80 |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | - |
| Dawn Colburn | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Moldt | M | 65 | 6 years | |
| Robert Duggan | M | 79 | 7 years | |
| Mahkam Zanganeh | M | 52 | 7 years | |
| Edgar Engleman | M | 78 | 9 years | |
| John Dunn | M | 72 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 1 years |
| Joseph J. Buggy | M | 57 | 17 years | |
| Steve Krognes | M | 56 | 5 years | |
| Edith Mitchell | M | 76 | 4 years | |
| Jack Taunton | M | - | - | |
| Simeon George | M | 46 | 9 years | |
| Randall Schatzman | M | 69 | 5 years | |
| Mary Ellen Smith | F | - |
The State University of New York
| 6 years |
| Christine Anna White | M | 72 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 12 years |
| Ashish Khanna | M | 52 | 3 years | |
| Erik Verner | M | - | 7 years | |
| William R. Scott | M | - |
The State University of New York
| 10 years |
| Turab Bajwa | M | - |
The University of Texas at Austin
| 5 years |
| James N. Lowder | M | 74 | - | |
| Kyle Hranicky | M | - |
The University of Texas at Austin
| 5 years |
| Phillip Schneider | M | 67 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 16 years |
| Mark Wiggins | M | 68 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | - |
| William R. Rohn | M | 80 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 10 years |
| William Rastetter | M | 76 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 17 years |
| David Dornan | M | 46 | 3 years | |
| Jason V. Coloma | M | - | - | |
| David J. Loury | M | 68 | - | |
| Yao Zhao | M | 60 |
The University of Texas at Austin
| 2 years |
| Karson Chang | M | - |
The University of Texas at Austin
| 4 years |
| John R. Gibb | M | 67 |
The State University of New York
| 4 years |
| Mitchell Lolley | M | - |
The University of Texas at Austin
| 4 years |
| Raj Miglani | M | - |
The University of Texas at Austin
| 2 years |
| Rahil Jiwan | M | - |
The University of Texas at Austin
| 4 years |
| Josh Braden | M | 42 |
The University of Texas at Austin
| 2 years |
| Blaine Dozier | M | - |
The University of Texas at Austin
| 4 years |
| Ken Grimes | M | 41 |
The University of Texas at Austin
| 4 years |
| Simi Kavthekar | F | - |
The University of Texas at Austin
| 4 years |
| Joseph A. Busch | M | - |
The State University of New York
| 3 years |
| Lawrence M. Harnett | M | - |
The State University of New York
| 4 years |
| Daniel L. Zito | M | - |
The State University of New York
| 4 years |
| Alan L. Zeiger | M | - |
The State University of New York
| 4 years |
| Philip B. Schwartz | M | - |
The State University of New York
| 4 years |
| Alan R. Ginsberg | M | - |
The State University of New York
| 4 years |
| Thomas V. Guarino | M | 70 |
The State University of New York
| 4 years |
| Christina Seix | F | - |
The State University of New York
| 2 years |
| Goldie Brandl | F | - |
The State University of New York
| 4 years |
| Leonard J. Stanley | M | 69 |
The State University of New York
| 4 years |
| Craig S. Medwick | M | - |
The State University of New York
| 4 years |
| Kevin McKinstrie | M | - |
The State University of New York
| 4 years |
| Cheryl A. Hoffman-Bray | F | 66 |
The State University of New York
| 4 years |
| Peter Jefrrey Reed | M | - |
The State University of New York
| 4 years |
| Ken Pasternak | M | - |
The State University of New York
| 4 years |
| Olutola O. Mobolurin | M | 72 |
The State University of New York
| 4 years |
| Ed Timmes | M | - |
The State University of New York
| 4 years |
| Robert H. Long | M | - |
The State University of New York
| 4 years |
| Lawrence S. Roberts | M | - |
The State University of New York
| 4 years |
| Robert Labenski | M | - |
The State University of New York
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 99.00% |
| China | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Miller
- Personal Network
